Clinical Trial Resources | Whitepapers & Webinars

[Webinar]Take The Pain Out Of Data Safety Monitoring Boards (DSMBs)

By attending this webinar you learn techniques and best practices to help reduce the challenges and stress of preparing for DSMBs.

[Webinar]COVID-19:Ensuring Scientific Integrity in Clinical Trials

By attending this webinar you will discover statistical methodologies which will help rescue your trial from the challenges caused by the COVID-19 pandemic.

Statistical Challenges in Preserving Integrity of Ongoing Clinical Trials during COVID-19

Challenges, potential solutions for maintaining scientific accuracy and regulatory compliance. biostatistics consultancy

Estimands: Strategies for Handling Intercurrent Events

Estimands have become an increasingly hot topic for statisticians within our industry. The ICH E9 R1 addendum is entitled ‘Estimands and sensitivity analysis in clinical trials’ and is expected to be finalized in the coming months.

[Webinar] Regulatory Submission Review

In this webinar, our presenters will provide guidance and support for those preparing a submission of their Investigational New Drug (IND) to regulatory bodies.

Design of Phase I Oncology Studies

This white paper explores the use of Model-based Designs in Phase I Oncology Studies, providing advantages and explanation for the slow uptake of this design method.

Real-World Data in Gene Therapy Trials

This Whitepaper gives examples of how real-world data helps the development of gene therapies by considering the contribution of conducting adequate and controlled studies.

Designing and Analyzing Hemophilia Clinical Trials

This Whitepaper focuses on designing and analyzing clinical trials for the treatment of Hemophilia A, exploring particularly the small population it effects, the slow recruitment rate and many other factors that should be considered.

CDISC Define.xml Guide

In this whitepaper, we will provide you with key points on how to prevent your CDISC Define.xml code from common mistakes using assumptions in the stylesheet; and simple adjustments and more complex examples.

Gene Therapy for Rare Diseases Webinar

In this webinar we will examine the challenges of rare diseases studies focusing on gene therapy treatments, including appropriate study design, statistical analyses and long-term post-authorization pharmacovigilance and risk management requirements.

Is Non-Responder the Best Imputation Method in Equivalence Trials?

This free webinar will illustrate how to assess Non-Responder Imputation Methods in Equivalence Trials.

The Benefits of Statistical Consultancy for Clinical Trials

Within this white paper you will be introduced to Statistical Consultancy for clinical trials and the benefits it can provide. Advice may cover issues from study design and strategies, to the analysis of study data and informed interpretation of results.

The Benefits of a Pharmacokinetics Handover Document in PK Studies

This paper illustrates the benefits of a Pharmacokinetics (PK) Handover Document in PK Studies and how such documents should be customized, detailing, ideally, what kind of information should be contained to transfer PK data between statistics and programming departments.

Statistical Monitoring in new ICH GCP E6(R2) Guidelines

This whitepaper introduces Statistical Monitoring and the creation of the Statistical Monitoring Report in response to a risk-based approach and the recent ICH GCP E6(R2) addendum.

Pharmacovigilance Database Compliance Webinar

This free webinar examines the E2B(R3) regulations and how this impacts database compliance from both a practical and technical perspective.

Pharmacovigilance Literature Searches

This paper on 'Pharmacovigilance (PV) Literature Searches' explores optimizing search strategies for patient safety and presents the elements and requirements for a successful PV literature search strategy.

SAS Macros in Clinical Trial Reporting

Within this whitepaper, we will look at some of the potential pitfalls with the production of SAS Macros and what makes a successful process improvement project. We will discuss approaches and solutions that we identified to typical problems.

Semi-Automated Patient Safety Narratives

This paper on 'Semi-Automated Patient Safety Narratives' explains what to do when a large volume of narratives is required within a restrictive time frame and details how a semi-automated approach to narrative writing can be used to address this challenge.

Remote Monitoring in Clinical Trials Webinar

In this webinar, you will learn how implementation, evolution and change management are critical for a successful remote monitoring program. But how does a remote monitoring program harmonize with current Source Data Verification practices?

The Key Considerations of Electronic Data Capture (EDC) System Selection

In today’s clinical trial environment you are likely to consider selecting an Electronic Data Capture (EDC) system, with few companies opting for paper based solutions. Yet with the rapid pace of technological advancement, it can prove increasingly difficult to identify the right electronic solution(s) for your study/development program.

Remote Source Document Verification (rSDV)

This ebook will explain rSDV's definition, present explored and piloted practices of conducting rSDV, the shortcomings of traditional monitoring and 100% SDV, and showcase the cost savings that can be incurred, as well as process efficiencies compared to traditional trial monitoring when using an rSDV approach.

The Challenges of Pharmacovigilance in Early Phase Clinical Trials Webinar

This free webinar looks at the challenges of pharmacovigilance in early phase clinical trials. We demonstrate the importance of PV in early phase clinical trials and how it is not just a check box exercise to satisfy regulatory bodies

Patient Safety Narratives in Clinical Studies

This paper describes current regulatory requirements with regards to patient safety narratives. It details a proposed process for their development and review and examines ways to lessen the burden of time and cost.

Sourcing Approaches within Clinical Development

This paper reviews the different approaches to sourcing in clinical development. Quanticate is seeing a wide range of sourcing scenarios and this paper assesses these different strategies.

Demonstrating Biosimilarity: Pharmacokinetic Considerations

In this white paper, we focus on some of the key issues which should be considered when performing pharmacokinetic analyses to prove clinical comparability between innovator biologics and recently developed biosimilars.

How to Save Money when Outsourcing and Selecting a Clinical Partner

This paper highlights some of the factors that can influence the cost and demonstrate value when selecting a partner in clinical development.

A balanced approach to program efficiency and data efficiency within Clinical Programming

This white paper looks at how the different perspectives to achieving efficiency in Clinical Programming can be achieved. This article explores balanced perspectives over narrow perspectives and how overall efficiencies and distinct efficiencies need to be separated.

Then and now: is clinical trial technology selection and implementation becoming easier?

As the choices for different clinical trial technologies grow, and the existing relationship between a sponsor and a CRO develops, the process of selecting a technology provider needs to examine a range of issues that didn't exist a few years ago.

CDISC CDASH Guide

SDTM standards do not always lead themselves well to data capture, this guide looks at using CDASH standards to provide a common ground to facilitate the capture of data when linking processes across clinical data management and clinical programming.

Translational Pharmacology: The Key to Ensuring Safe and Effective Dosing

PKPD models are becoming increasingly critical knowledge-building tools, not only for late phase clinical trials but throughout the entire drug development process.

Integrated Summaries of Safety and Efficacy: The Role of the Medical Writer

This paper looks at how a Medical Writer should contribute to the production of a quality ISS/ISE. It follows a previous white paper on the role of Statisticians and Programmers in the production of integrated summaries.

Phase 1 Studies: Roles and Obligations of the Medical Writer

This article outlines the support needed from medical writers during the design, conduct and reporting of Phase I studies, but also their obligations when it comes to publishing results.

PK/PD Models: Reducing Phase 3 Attrition Rates

This short article outlines how thorough PK/PD modelling can significantly reduce the risk of failure in Phase 3 trials.

Overview of Challenges in Oncology Studies

If you are planning an oncology study, you will be aware that these studies are more complex than others. Our consultancy team at Quanticate have put together an initial article that outlines the typical challenges presented by such studies and offers some recommendations to counter them.

Clinical SAS Programming Efficiently with Large SAS Datasets

Clinical Trial Whitepapers & Webinars

CONTACT DETAILS

QUANTICATE

BLOG TOPICS

FOLLOW QUANTICATE ON: